Mark Lawrence Rubinstein's most recent trade in Achieve Life Sciences Inc. was a trade of 180,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Mark Lawrence Rubinstein | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 180,000 | 180,000 | - | - | Stock Option (right to buy) |